BioVectra is a Manufacturer/Innovator company operating in the pharmaceutical industry.
BIOVECTRA is a global biotech and pharmaceutical CDMO that specializes in clinical-to-commercial scale production capabilities for biologics, small molecules, bioreagents, and pDNA and mRNA manufacturing. Flexibility, creativity, process optimization, and compliance are at the heart of our method. With more than 50 years of experience, over 630 employees, and cGMP facilities in Prince Edward Island and Nova Scotia, Canada we assure our programs advance on time and with the highest quality outcomes. Learn more about BIOVECTRA today!
Company type
Manufacturer/Innovator
Products and services
Biopharmaceuticals, Custom Manufacturing, Intermediates, Fine and Specialty Chemicals, Contract Services – Analytical & Lab Services, Pharmaceutical Machinery & Technology
Markets
Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Useful Links
Connect with BioVectra on LinkedIn
Address
BioVectra, 11 Aviation Ave, Charlottetown, PE, Canada, C1E 0A1